Home > Insider Trading > Filing (0001494650-20-000163)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494650	Optinose Inc.	OPTN	Pharmaceutical Preparations (2834)	421771610

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1718725	A Ramy Mahmoud	C/O Optinose, Inc. 1020 Stony Hill Road, Suite 300 Yardley PA 19067	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-23	85,016	$1.63	216,504	No	4	M	Direct
Common Stock	Disposition	2020-12-23	23,436	$4.03	193,068	No	4	S	Direct
Common Stock	Disposition	2020-12-23	34,013	$4.03	159,055	No	4	F	Direct
Common Stock	Acquisiton	2020-12-23	28,342	$1.63	54,573	No	4	M	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock	Disposition	2020-12-23	7,835	$4.03	46,738	No	4	S	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock	Disposition	2020-12-23	11,012	$4.03	35,726	No	4	F	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct
No	4	M	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No	4	S	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No	4	F	Indirect	By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-23	85,016	$0.00	85,016	$1.63
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-23	28,341	$0.00	28,341	$1.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-02-11	No	4	M	Direct
0		2021-02-11	No	4	M	Indirect

Footnotes

The reporting person previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On December 23, 2020, 85,016 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 27,567 shares of common stock, the cancellation of 34,013 option shares in satisfaction of the exercise price for such options and the sale of 23,436 shares to cover estimated withholding taxes in connection with and exercise price of such exercise.
The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud (the "Trust") previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On December 23, 2020, 28,341 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 9,494 shares of common stock, the cancellation of 11,012 option shares in satisfaction of the exercise price for such options and the sale of 7,835 shares to cover estimated withholding taxes in connection with such exercise.
Shares held by The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud, the beneficiary of which is Dr. Mahmoud's spouse.
All option shares are exercisable.